This inventor holds 2 USPTO granted patents. Top assignees: Piramal Enterprises Limited, Piramal Pharma Limited. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2022
Title: Sandesh Vishwasrao: Innovator in SGLT2 Inhibitors
Introduction
Sandesh Vishwasrao is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of SGLT2 inhibitors. With a total of two patents to his name, his work is recognized for its industrial feasibility and economic viability.
Latest Patents
Vishwasrao's latest patents include a process for the preparation of SGLT2 inhibitors and intermediates thereof. This invention relates to an industrially feasible and economically viable process for the preparation of SGLT2 inhibitors of formula X in significantly high yield and purity. Additionally, he has developed a process for the preparation of Bexagliflozin of formula V, which also achieves high yield and purity.
Career Highlights
Throughout his career, Sandesh Vishwasrao has worked with prominent companies such as Piramal Pharma Limited and Piramal Enterprises Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Some of his notable coworkers include Milind Moreshwar Gharpure and Sanjay Kumar Sharma. Their collaboration has likely played a role in advancing their shared goals in the pharmaceutical industry.
Conclusion
Sandesh Vishwasrao's contributions to the development of SGLT2 inhibitors highlight his innovative spirit and dedication to improving pharmaceutical processes. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile